A phase III, randomized, double-blind, placebo-controlled study to confirm the effectiveness and safety of ALGRX 3268 [lidocaine] in pediatric subjects

Trial Profile

A phase III, randomized, double-blind, placebo-controlled study to confirm the effectiveness and safety of ALGRX 3268 [lidocaine] in pediatric subjects

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Jul 2015

At a glance

  • Drugs Lidocaine (Primary)
  • Indications Procedural pain
  • Focus Registrational; Therapeutic Use
  • Acronyms COMFORT-003
  • Most Recent Events

    • 01 May 2008 Results have been published.
    • 11 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top